These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20206758)

  • 1. Apixaban to prevent venous thromboembolism after knee replacement.
    Fareed J; Hull R
    Lancet; 2010 Mar; 375(9717):779-80. PubMed ID: 20206758
    [No Abstract]   [Full Text] [Related]  

  • 2. Apixaban or enoxaparin for thromboprophylaxis.
    Gómez-Outes A; Suárez-Gea ML; Pozo-Hernández C
    N Engl J Med; 2009 Nov; 361(21):2100-1; author reply 2101. PubMed ID: 19923583
    [No Abstract]   [Full Text] [Related]  

  • 3. Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial.
    Lassen MR; Raskob GE; Gallus A; Pineo G; Chen D; Hornick P;
    Lancet; 2010 Mar; 375(9717):807-15. PubMed ID: 20206776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement: pooled analysis of major venous thromboembolism and bleeding in 8464 patients from the ADVANCE-2 and ADVANCE-3 trials.
    Raskob GE; Gallus AS; Pineo GF; Chen D; Ramirez LM; Wright RT; Lassen MR
    J Bone Joint Surg Br; 2012 Feb; 94(2):257-64. PubMed ID: 22323697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apixaban versus enoxaparin in patients with total knee arthroplasty. A meta-analysis of randomised trials.
    Huang J; Cao Y; Liao C; Wu L; Gao F
    Thromb Haemost; 2011 Feb; 105(2):245-53. PubMed ID: 20941455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apixaban or enoxaparin for thromboprophylaxis after knee replacement.
    Lassen MR; Raskob GE; Gallus A; Pineo G; Chen D; Portman RJ
    N Engl J Med; 2009 Aug; 361(6):594-604. PubMed ID: 19657123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Canadian study of the cost-effectiveness of apixaban compared with enoxaparin for post-surgical venous thromboembolism prevention.
    Revankar N; Patterson J; Kadambi A; Raymond V; El-Hadi W
    Postgrad Med; 2013 Jul; 125(4):141-53. PubMed ID: 23933902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apixaban vs. enoxaparin after hip replacement.
    Jameson SS; Sanders RD; Reed MR
    N Engl J Med; 2011 Mar; 364(12):1177; author reply 1177. PubMed ID: 21428776
    [No Abstract]   [Full Text] [Related]  

  • 9. Apixaban versus enoxaparin for thromboprophylaxis after hip replacement.
    Lassen MR; Gallus A; Raskob GE; Pineo G; Chen D; Ramirez LM;
    N Engl J Med; 2010 Dec; 363(26):2487-98. PubMed ID: 21175312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and safety of apixaban, an oral, direct factor Xa inhibitor, as thromboprophylaxis in patients following total knee replacement.
    Lassen MR; Davidson BL; Gallus A; Pineo G; Ansell J; Deitchman D
    J Thromb Haemost; 2007 Dec; 5(12):2368-75. PubMed ID: 17868430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apixaban versus enoxaparin in the prevention of venous thromboembolism following total knee arthroplasty: a single-centre, single-surgeon, retrospective analysis.
    King DA; Pow RE; Dickison DM; Vale PR
    Intern Med J; 2016 Sep; 46(9):1030-7. PubMed ID: 27246450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cost-effectiveness analysis of apixaban compared to dabigatran in the prevention of venous thromboembolism in patients subjected to total knee or hip replacement].
    Gómez-Cerezo JF; Gómez-Arrayás I; Suárez-Fernández C; Betegón-Nicolás L; de Salas-Cansado M; Rubio-Terrés C
    Rev Esp Cir Ortop Traumatol; 2012; 56(6):459-70. PubMed ID: 23594943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dabigatran, rivaroxaban and apixaban versus enoxaparin for thomboprophylaxis after total knee or hip arthroplasty: pool-analysis of phase III randomized clinical trials.
    Nieto JA; Espada NG; Merino RG; González TC
    Thromb Res; 2012 Aug; 130(2):183-91. PubMed ID: 22425218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apixaban versus enoxaparin in elective major orthopedic surgery: a clinical review.
    Maniscalco P; Caforio M; Imberti D; Porcellini G; Benedetti R
    Clin Appl Thromb Hemost; 2015 Mar; 21(2):115-9. PubMed ID: 25125051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost Effectiveness of Apixaban and Enoxaparin for the Prevention of Venous Thromboembolism After Total Knee Replacement in China.
    Yan X; Gu X; Zhou L; Lin H; Wu B
    Clin Drug Investig; 2016 Dec; 36(12):1001-1010. PubMed ID: 27581246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical use of apixaban in the prevention of venous thromboembolism after total knee or hip replacement.
    Lassen MR
    Drugs Today (Barc); 2012 Apr; 48(4):249-58. PubMed ID: 22536567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential of apixaban in the prevention of venous thromboembolism in patients undergoing total knee replacement surgery.
    Martin MT; Nutescu EA
    Curr Med Res Opin; 2011 Nov; 27(11):2123-31. PubMed ID: 21942466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apixaban versus enoxaparin for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis of randomized controlled trials.
    Li XM; Sun SG; Zhang WD
    Chin Med J (Engl); 2012 Jul; 125(13):2339-45. PubMed ID: 22882859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apixaban versus enoxaparin in medically ill patients.
    Yang ZY; Mao C; Jin-Ling TJ
    N Engl J Med; 2012 Feb; 366(8):767; author reply 767-8. PubMed ID: 22356339
    [No Abstract]   [Full Text] [Related]  

  • 20. Apixaban: a review of its use in the prevention of venous thromboembolism after knee or hip replacement surgery.
    Deeks ED
    Drugs; 2012 Jun; 72(9):1271-91. PubMed ID: 22686618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.